Gossamer Bio, Inc. Common Stock GOSS
$0.15
-9.45%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (5 Buy · 2 Hold · 1 Sell)
- Average Price Target
- $2.90
- Implied Upside
- +1778.8%
- Price Target Range
- $0.28 – $9.00
- Analysts (12 mo)
- 8
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-14 | Piper SandlerYasmeen Rahimi |
Maintains | Overweight | $15 → $4 |
| 2026-07-28 | Leerink PartnersJoseph Schwartz |
Upgrades | Market perform → Outperform | $1 |
| 2026-07-27 | HC Wainwright & Co.Patrick R. Trucchio |
Reiterates | Buy | $2 |
| 2026-06-25 | HC Wainwright & Co.Patrick R. Trucchio |
Maintains | Buy | $5 → $2 |
| 2026-05-26 | HC Wainwright & Co.Patrick R. Trucchio |
Reiterates | Buy | $5 |
| 2026-05-19 | BarclaysEliana Merle |
Maintains | Underweight | $0 → $0 |
| 2026-03-23 | Cantor FitzgeraldOlivia Brayer |
Downgrades | Overweight → Neutral | — |
| 2026-03-06 | HC Wainwright & Co.Patrick R. Trucchio |
Maintains | Buy | $10 → $5 |
| 2026-03-05 | OppenheimerAndreas Argyrides |
Maintains | Outperform | $12 → $3 |
| 2026-02-24 | WedbushLaura Chico |
Downgrades | Outperform → Neutral | $6 → $1 |
| 2026-02-24 | BarclaysEliana Merle |
Downgrades | Overweight → Underweight | $9 → $0 |
| 2026-02-24 | Leerink PartnersJoseph Schwartz |
Downgrades | Outperform → Market perform | $6 → $1 |
| 2026-01-28 | BarclaysEliana Merle |
Initiates coverage on | Overweight | $9 |
| 2026-01-22 | HC Wainwright & Co.Patrick R. Trucchio |
Reiterates | Buy | $10 |
| 2025-09-11 | Cantor FitzgeraldOlivia Brayer |
Reiterates | Overweight | — |
| 2025-09-10 | UBSEliana Merle |
Upgrades | Neutral → Buy | $1 → $9 |
| 2025-08-06 | WedbushLaura Chico |
Maintains | Outperform | $4 → $5 |
| 2025-07-14 | ScotiabankGreg Harrison |
Initiates coverage on | Sector outperform | $11 |
| 2025-05-16 | Goldman SachsPaul Choi |
Maintains | Buy | $7 → $8 |
| 2025-05-16 | WedbushLaura Chico |
Reiterates | Outperform | $4 |
| 2025-04-17 | Goldman SachsPaul Choi |
Maintains | Buy | $8 → $7 |
| 2025-03-18 | HC Wainwright & Co.Patrick Trucchio |
Reiterates | Buy | $10 |
| 2025-03-14 | WedbushLaura Chico |
Reiterates | Outperform | $4 |
| 2025-01-30 | HC Wainwright & Co.Patrick Trucchio |
Reiterates | Buy | $10 |
| 2024-11-11 | HC Wainwright & Co.Patrick Trucchio |
Reiterates | Buy | $10 |
| 2024-09-17 | HC Wainwright & Co.Patrick Trucchio |
Reiterates | Buy | $10 |
| 2024-08-30 | HC Wainwright & Co.Patrick Trucchio |
Reiterates | Buy | $10 |
| 2024-08-13 | WedbushLaura Chico |
Reiterates | Outperform | $4 |
| 2024-06-25 | OppenheimerAndreas Argyrides |
Initiates coverage on | Outperform | $9 |
| 2024-06-17 | Goldman SachsPaul Choi |
Maintains | Buy | $8 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $0.15
- Market Cap
- $86.82 million
- 52-Week Range
- $0.11 – $3.87
- Average Volume
- 35.41 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.